SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-045930
Filing Date
2022-08-09
Accepted
2022-08-09 16:38:49
Documents
65
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_180lifesci.htm   iXBRL 10-Q 834271
2 CERTIFICATION f10q0622ex31-1_180lifescien.htm EX-31.1 9466
3 CERTIFICATION f10q0622ex31-2_180lifescien.htm EX-31.2 9444
4 CERTIFICATION f10q0622ex32-1_180lifescien.htm EX-32.1 3152
5 CERTIFICATION f10q0622ex32-2_180lifescien.htm EX-32.2 3086
6 GRAPHIC image_001.jpg GRAPHIC 2301
  Complete submission text file 0001213900-22-045930.txt   4996637

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE atnf-20220630.xsd EX-101.SCH 66540
8 XBRL CALCULATION FILE atnf-20220630_cal.xml EX-101.CAL 29925
9 XBRL DEFINITION FILE atnf-20220630_def.xml EX-101.DEF 255622
10 XBRL LABEL FILE atnf-20220630_lab.xml EX-101.LAB 554676
11 XBRL PRESENTATION FILE atnf-20220630_pre.xml EX-101.PRE 273986
59 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_180lifesci_htm.xml XML 568448
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38105 | Film No.: 221148974
SIC: 2834 Pharmaceutical Preparations